U.S. Orthopedic Devices Market Revenue & Forecast Analysis, 2026-2035
The U.S. orthopedic devices market was evaluated at USD 25.5 billion in 2025 and is projected to grow at a CAGR of 4.3% from USD 26.3 billion in 2026 to USD 38.5 billion in 2035. The market growth is primarily driven by the increasing prevalence of musculoskeletal disorders and degenerative bone conditions requiring surgical intervention. Additionally, the growing geriatric population susceptible to joint and spine-related ailments, rising incidence of sports and trauma injuries, expanding adoption of minimally invasive orthopedic procedures, and ongoing technological innovations in implants and robotic-assisted orthopedic systems are supporting the growth of the U.S. orthopedic devices market.
Market Overview
According to the 2023 American Joint Replacement Registry (AJRR) Annual Report published by the American Academy of Orthopaedic Surgeons, more than 3.1 million primary and revision hip and knee arthroplasty procedures were recorded across the United States between 2012 and 2022, highlighting the growing utilisation of orthopedic implants and advanced joint replacement devices in clinical practice.
The U.S. orthopedic devices market has grown steadily over the years, supported by continuous advancements in implant materials and fixation technologies, increasing volumes of joint replacement procedures, and the expansion of specialised orthopedic care services across healthcare facilities. The adoption of robotic-assisted and computer-guided orthopedic surgeries has further strengthened procedural accuracy and market penetration. For instance, according to the 2024 American Academy of Orthopaedic Surgeons report, approximately 790,000 total knee replacements and over 450,000 hip replacements are performed annually in the United States, reflecting the strong demand for orthopedic implants and contributing to market growth.
The U.S. orthopedic devices market is projected to experience significant growth throughout the forecast period due to increasing investments in orthopedic surgical infrastructure, expanding access to advanced musculoskeletal treatment options, and the growing demand for mobility-restoring procedures among aging populations. The rising integration of robotics and digital surgical planning technologies is also contributing to market expansion. For instance, by 2035, U.S. healthcare providers are expected to expand the adoption of next-generation orthopedic implant systems to enhance surgical precision and long-term patient outcomes.
U.S. Orthopedic Devices Market Overview
Base Year Market Size (2025): USD 25.5 Billion
CAGR: 4.3%
Forecast Year Market Size (2035): USD 38.5 Billion
Major Players:
Stryker Corporation
DePuy Synthes (Johnson & Johnson MedTech)
Zimmer Biomet Holdings, Inc.
Medtronic plc
Globus Medical, Inc.
U.S. Orthopedic Devices Market Trends
The U.S. orthopedic devices market is evolving rapidly due to the increasing integration of smart orthopedic technologies, growing focus on outpatient orthopedic care, and the expanding use of data-driven surgical decision-making tools.
· The increasing adoption of wearable monitoring technologies is enabling healthcare providers to track post-operative recovery and rehabilitation progress more effectively.
· The growing shift toward ambulatory surgery centers for orthopedic procedures is improving treatment accessibility while reducing overall healthcare costs.
· The rising utilisation of sensor-enabled orthopedic implants is supporting real-time performance assessment and enhanced patient management.
· The increasing incorporation of artificial intelligence and predictive analytics into orthopedic workflows is assisting clinicians in optimising treatment planning and patient outcomes.
Collectively, these trends are expected to support the continued growth of the U.S. orthopedic devices market by enhancing care delivery efficiency, improving patient monitoring capabilities, and advancing orthopedic treatment effectiveness.
U.S. Orthopedic Devices Market Analysis
By Product Type
Joint Replacement/Orthopedic Implants dominate the U.S. orthopedic devices market due to rising joint replacement procedures
Based on product type, the U.S. orthopedic devices market is categorised into joint replacement/orthopedic implants, trauma, sports medicine, orthobiologics, and others. The joint replacement/orthopedic implants segment leads the market with the highest market share in 2025.
By End-use
Hospitals dominate the U.S. orthopedic devices market owing to high surgical procedure volumes.
Based on end-use, the U.S. orthopedic devices market is categorised into hospitals and outpatient facilities. The hospitals segment leads the market with the highest market share in 2025.
Key Companies Profiled
The U.S. orthopedic devices market features a competitive landscape with leading medical technology companies competing through innovative orthopedic implant systems, trauma fixation solutions, sports medicine products, and advanced musculoskeletal treatment portfolios. Key players such as Stryker Corporation, DePuy Synthes, Zimmer Biomet Holdings, Inc., Medtronic plc, and Globus Medical, Inc. hold a significant share of the market, supported by extensive product offerings, strong distribution capabilities, and continuous investment in research and development.
The market is highly competitive, with companies focusing on next-generation implant technologies, procedural efficiency improvements, and integrated orthopedic care solutions to strengthen their market positions. The increasing volume of orthopedic procedures, growing demand for mobility restoration treatments, and ongoing advancements in orthopedic device engineering are further intensifying competition across the market.
U.S. Orthopedic Devices Market Companies:
Some of the key companies operating in the U.S. Orthopedic Devices Market include:
Aesculap, Inc. (B. Braun)
Alphatec Holdings, Inc.
Arthrex, Inc.
CONMED Corporation
DePuy Synthes (Johnson & Johnson MedTech)
Enovis Corporation
Globus Medical, Inc.
Medtronic plc
Orthofix Medical Inc.
SeaSpine Holdings Corporation
Smith+Nephew plc
Stryker Corporation
Wright Medical Group N.V.
Zimmer Biomet Holdings, Inc.
ZimVie Inc.
Market Segmentation
This study provides revenue growth and emerging trends across the U.S. levels from 2021 to 2035, segmenting the U.S. orthopedic devices market by-
Product Type (Revenue in USD Million, 2021 - 2035)
Joint Replacement/ Orthopedic Implants
Trauma
Sports Medicine
Orthobiologics
Others
End-use (Revenue in USD Million, 2021 – 2035)
Hospitals
Outpatient Facilities
Table of Content
1. Methodology and Scope
1.1. Scope of the Study
1.1.1. Market Segmentation
1.1.2. Market Definition
1.1.3. Inclusions and Exclusions of the Study
1.2. Research Design
1.2.1. Base Year, Historical Data, and Forecast Period
1.2.2. Data Collection Methods
1.2.2.1. Secondary Sources
1.2.2.2. Primary Sources
1.2.3. Research Methodology
1.2.3.1. Base Year Calculation/ Parent Market Analysis, Company/ Brand Share Analysis, 2025 (Top-down Approach)
1.2.3.2. Volume-Price Approach (Bottom-up Approach)
1.2.3.3. Data Triangulation
1.2.4. Forecasting Model
1.3. Research Assumptions
1.4. Validation and Data Quality Control
1.5. List of Primary Sources
1.6. List of Secondary Sources
2. Executive Summary
2.1. Market Overview
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
3. Industry Outlook
3.1. Industry Ecosystem Analysis
3.2. Parent/ Ancillary Market Analysis
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Restraints/ Challenges
3.3.3. Opportunities
3.4. Value Chain Analysis
3.5. Technology Roadmap
3.6. Porters Analysis
3.7. PESTLE Analysis
4. Market Estimates and Forecasts, By Product Type, 2021 - 2035 (Market Size in USD Mn)
4.1. Joint Replacement/ Orthopedic Implants
4.2. Trauma
4.3. Sports Medicine
4.4. Orthobiologics
4.5. Others
5. Market Estimates and Forecasts, By End-use, 2021 – 2035 (USD Mn)
5.1. Hospitals
5.2. Outpatient Facilities
6. Market Estimates and Forecasts, By U.S., 2021 - 2035 (USD Mn)
6.1.1. U.S.
6.1.1.1. U.S. Orthopedic Devices Market Estimates and Forecasts to 2035 (USD Mn)
6.1.1.2. Market Dynamics
6.1.1.3. Competitive Landscape
6.1.1.4. Regulatory Framework
6.1.1.5. Reimbursement Scenario
7. Competitive Landscape
7.1. Company Market Share Analysis, 2025
7.2. Company Tier Structure
7.3. List of Major Suppliers, By Key Countries
7.4. Key Company Positioning Analysis
7.5. Company Profile
7.5.1. Aesculap, Inc. (B. Braun)
7.5.2. Alphatec Holdings, Inc.
7.5.3. Arthrex, Inc.
7.5.4. CONMED Corporation
7.5.5. DePuy Synthes (Johnson & Johnson MedTech)
7.5.6. Enovis Corporation
7.5.7. Globus Medical, Inc.
7.5.8. Medtronic plc
7.5.9. Orthofix Medical Inc.
7.5.10. SeaSpine Holdings Corporation
7.5.11. Smith+Nephew plc
7.5.12. Stryker Corporation
7.5.13. Wright Medical Group N.V.
7.5.14. Zimmer Biomet Holdings, Inc.
7.5.15. ZimVie Inc.
8. Analyst Perspective
9. Related Reports
Revolution Insights Briefs
Stay informed with updates on related market reports and key industry topics.